Latest News
Amprius Technologies Shares Rally 26% Amid Insider Sales and Short-Seller Report
Amprius Technologies shares surged 26.5% to $21.70 on heavy volume, fueled by insider sales, a short-seller report, and strong Q1 results. The company raised its 2026 revenue forecast.
Marvell Rises on $10B Custom Chip Forecast, AI Demand Drives Growth
Marvell Technology shares rose 2.4% to $203.50 after forecasting $10B+ in custom-chip revenue by fiscal 2029, with Q1 revenue up 28% to $2.418B. AI bookings surged and data center sales made up 76% of total revenue.
AMD Surges 5% as AI Infrastructure Bets Revive Chip Sector Rally
AMD shares surged 5.1% to $520.93 on Thursday, leading chip stocks higher on renewed AI demand and a $10B investment in Taiwan's chip ecosystem.
Photronics Plunges 32% on Q2 Revenue Miss and Weak Outlook
Photronics shares fell 32% after missing Q2 estimates and cutting guidance, with IC revenue down 5% year over year.
CIBC Stock Dips Despite Strong Earnings and Caribbean Asset Sale
CIBC shares fell 5.5% despite beating Q2 profit estimates and announcing the sale of its Caribbean unit for about $1.6 billion.
Arm Soars on Nvidia Vera CPU Ties, Record Revenue
Arm shares jumped 12.7% on upbeat analyst notes tying it to Nvidia's Vera CPU. Record revenue of $4.92 billion and $2 billion in AGI CPU demand through 2028 fuel the rally.
Oracle's AI Data Center Strategy Faces Scrutiny Amid Debt and Backlog Concerns
Oracle shares gained 6.2% after strong Q3 results, but investors eye $552.6B backlog and $130.9B debt as AI data-center costs mount.
Snowflake Stock Surges on $6B AWS Deal, Raised Outlook
Snowflake shares surged over 33% following a $6 billion AWS deal and an upbeat fiscal 2027 revenue forecast, prompting at least 30 analysts to raise price targets.
Super Micro Shares Jump on Taiwan Seizure and European AI Cloud Deal
Super Micro shares surged 6.2% after Taiwan officials arrested three suspects and seized 50 servers in an export case, while the company announced a major AI cloud deal with Verda in Europe.
Lilly Expands Vaccine Portfolio with $3.83B Triple Acquisition
Eli Lilly acquires Curevo, LimmaTech, and Vaccine Company for up to $3.83B, gaining vaccine candidates for shingles, staph, and Epstein-Barr virus. Shares rose 5%.